85 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
ADUS Addus HomeCare Corporation $68.95 $806.53M Downtrend
Article Searches
Use Rising P/E Tactic to Find Out 5 Winning Stocks http://www.zacks.com/stock/news/261331/use-rising-p-e-tactic-to-find-out-5-winning-stocks?cid=CS-ZC-FT-261331 May 22, 2017 - Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.
New Strong Buy Stocks for May 17th http://www.zacks.com/commentary/114108/new-strong-buy-stocks-for-may-17th?cid=CS-ZC-FT-114108 May 17, 2017 - New Strong Buy Stocks for May 17th
Conatus (CNAT) Q1 Loss Narrows Y/Y, Revenues Beat Estimates http://www.zacks.com/stock/news/259598/conatus-cnat-q1-loss-narrows-y-y-revenues-beat-estimates?cid=CS-ZC-FT-259598 May 05, 2017 - Conatus Pharmaceuticals Inc. (CNAT) reported first-quarter 2017 loss of 14 cents per share, in line with the Zacks Consensus Estimate but narrower than the year-ago figure of 35 cents.
Addus HomeCare Is Positioned For Long-Term Growth https://seekingalpha.com/article/4060029-addus-homecare-positioned-long-term-growth?source=feed_all_articles Apr 04, 2017 - Addus HomeCare has demographics shifting in its favor. The company has a well grounded balance sheet and room to grow. Its small market cap and nonexistent trade volume suggest it is underfollowed.
Favorable Business Dynamics Can Change Addus HomeCare's Fortunes In 2017 https://seekingalpha.com/article/4059738-favorable-business-dynamics-can-change-addus-homecares-fortunes-2017?source=feed_tag_long_ideas Apr 03, 2017 - Changing demographics, business dynamics, and increasing focus on containing healthcare costs are key growth drivers for Addus HomeCare.Dual eligibles segment is a strong growth opportunity for the co
Orexigen Posts Wider-than-Expected Loss in Q4; Sales Up Y/Y http://www.zacks.com/stock/news/254558/orexigen-posts-wider-than-expected-loss-in-q4-sales-up-y-y?cid=CS-ZC-FT-254558 Mar 29, 2017 - Orexigen Therapeutics, Inc.???s (OREX) loss of $2.67 per share in the fourth quarter of 2016, significantly wider than the both Zacks Consensus Estimate of a loss of 54 cents and the year-ago loss of $1.20.
Novo Nordisk: Positive CHMP Nod for Tresiba Label Expansion http://www.zacks.com/stock/news/254428/novo-nordisk-positive-chmp-nod-for-tresiba-label-expansion?cid=CS-ZC-FT-254428 Mar 28, 2017 - Novo Nordisk A/S (NVO) announced that the Committee for Medicinal Products for Human Use (CHMP), has issued a positive opinion suggesting an update to the label for Tresiba (insulin degludec) to include data from the SWITCH studies.
VIVUS to Regain Commercial Rights for Stendra from Sanofi http://www.zacks.com/stock/news/254404/vivus-to-regain-commercial-rights-for-stendra-from-sanofi?cid=CS-ZC-FT-254404 Mar 28, 2017 - VIVUS, Inc. (VVUS) recently announced an agreement with Sanofi to reacquire the commercial rights to its erectile dysfunction drug, Stendrain Africa, the Middle East, Turkey and the Commonwealth of Independent States, including Russia.
Roche's Rituxan Gets 'Breakthrough Therapy' Designation by FDA http://www.zacks.com/stock/news/254097/roches-rituxan-gets-breakthrough-therapy-designation-by-fda?cid=CS-ZC-FT-254097 Mar 24, 2017 - Roche Holding AG's (RHHBY) member, Genentech announced that the FDA has granted Breakthrough Therapy Designation status to Rituxan (rituximab) for the treatment of pemphigus vulgaris.
Allergan's Restasis Now Available in Multidose Bottle in U.S. http://www.zacks.com/stock/news/253868/allergans-restasis-now-available-in-multidose-bottle-in-us?cid=CS-ZC-FT-253868 Mar 23, 2017 - Allergan plc (AGN) recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S.

Pages: 123456789

<<<Page 6>